Back to Search Start Over

The European Respiratory Journal : the ERS flagship heads for the next frontier.

Authors :
Chalmers JD
Sin DD
Source :
The European respiratory journal [Eur Respir J] 2023 Jan 12; Vol. 61 (1). Date of Electronic Publication: 2023 Jan 12 (Print Publication: 2023).
Publication Year :
2023

Abstract

Competing Interests: Conflict of interest: J.D. Chalmers has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Grifols, Novartis, Insmed and Trudell, and received consultancy or speaker fees from Antabio, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Janssen, Novartis, Pfizer, Trudell and Zambon. D.D. Sin has received a stipend for giving talks on COPD from AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim.

Details

Language :
English
ISSN :
1399-3003
Volume :
61
Issue :
1
Database :
MEDLINE
Journal :
The European respiratory journal
Publication Type :
Editorial & Opinion
Accession number :
36634923
Full Text :
https://doi.org/10.1183/13993003.02475-2022